CD44s在肺癌中的表达及其意义

目的:探讨CD44s在肺癌组织中的表达及其临床意义。方法:采用免疫组化方法检测117例原发性肺癌的CD44s异常表达。结果:CD44s在小细胞肺癌(SCLC)不表达,而表达于非小细胞肺癌(NSCLC)中,并且鳞癌的CD44s表达强度明显强于腺癌(P＜0.05);未发生淋巴结转移的肺癌病例中CD44s的表达明显高于已经发生转移的病例(P＜0.01);按照临床肿瘤TNM分期,早期肺癌的CD44s表达显著高于进展期肺癌(P＜0.05)。结论:CD44s对肺癌组织的病理类型、淋巴结转移、临床分期以及预后的判断是一个较好的评价指标。

Expression of CD44s in lung cancer and its significance

AIM: To investigate expression of CD44s in lung cancer and it's clinical significance. METHODS: A total of 117 primary lung cancer from patients were examined for CD44s expression by immunohistochemical staining. RESULTS: CD44s mostly expressed in non-small cell lung cancer (NSCLC) but not in small ecll lung cancer (SCLC), and squamous cell carcinoma(SCC) showed much stronger expression of CD44s than adenocarcinoma(ADC)(P<0.05). In comparison of the lung cancer with/ without lymph node metastasis, the latter showed stronger expression of CD44s(P<0.01). According to TNM, there was a distinct statistic difference between early stage and advanced stage(P<0.05). CONCLUSION: CD44s might be a better indicant in histological classification of lung cancer, lymph node metastasis, clinical stage and prognosis.